Screener
Turn Therapeutics Inc. TTRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $109.43K+1,082% | $34.93K+258% | $158.7K+3.5% | $62.68K— | $9.26K— | ||
| $1.14M+203% | $2.16M+576% | $1.75M+238% | $1.3M— | $375.74K— | ||
| $1.25M+224% | $2.19M+567% | $1.91M+184% | $1.37M— | $385K— | ||
| -$1.25M-224% | -$2.19M-567% | -$1.91M-184% | -$1.37M— | -$385K— | ||
| $275.17K+387% | $2.47M+42,334% | $9.37K+43.1% | $126.11K— | $56.45K— | ||
| -$970.97K-196% | —— | -$1.9M-186% | —— | -$328.55K— | ||
| -$0.03-200% | —— | -$0.07-133% | —— | -$0.01— | ||
| -$1.25M-224% | -$2.19M-567% | -$1.91M-184% | -$1.37M— | -$385K— |
FAQ
- Is Turn Therapeutics Inc. profitable?
- Turn Therapeutics Inc. is not currently profitable: it reported a net loss of $3.5M over the trailing twelve months.
- What is Turn Therapeutics Inc.'s earnings per share?
- Turn Therapeutics Inc.'s diluted EPS over the trailing twelve months is $-0.13.
- Where does Turn Therapeutics Inc.'s income statement data come from?
- Every line is extracted from Turn Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.